The activity of N-acetyl-beta-d-glucosaminidase and tumor necrosis factor-alpha at early stage of diabetic retinopathy development in type 1 diabetes mellitus children

Clinical Biochemistry

Volumn 39, Issue 8, 2006, Pages 851-856

  Myśliwiec, Małgorzata ^a   Zorena, Katarzyna ^a   Balcerska, Anna ^a   Myśliwska, Jolanta ^a   Lipowski, Paweł ^a   Raczyńska, Krystyna ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Children; Diabetes Mellitus type; IL 10; NAG; Retinopathy; TNF

Indexed keywords

INTERLEUKIN 10; N ACETYL BETA GLUCOSAMINIDASE; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ARTICLE; CHILD; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE RELEASE; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME BLOOD LEVEL; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD; SCREENING;

ACETYLGLUCOSAMINIDASE; ADOLESCENT; CHILD; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; FEMALE; HUMANS; INTERLEUKIN-10; MALE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33746889036     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2006.03.013     Document Type: Article

References (43)

1. Silink M. Global impact of diabetes. Pediatr Diabetes 6 suppl. 3 (2005)
2. Sochett E., and Daneman D. Early diabetes-related complacations in children and adolescents with type 1 diabetes. Endocrinol Metab Clin North Am 28 (1999) 865-881
3. Danne T., Kordonouri O., Enders I., and Hovener G. Monitoring for retinopathy in children and adolescents with type 1 diabetes. Acta Paediatr Suppl 425 (1998) 35-41
4. Schram M.T., Chaturvedi N., Schalkwijk C., Giorgino F., Ebeling P., Fuller J.H., et al., EURODIAB Prospective Complications Study. Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetes Care 26 (2003) 2165-2173
5. Price R.G. The role of NAG (N-acetyl-beta-d-glucosaminidase) in the diagnosis of kidney disease including the monitoring of nephrotoxicity. Clin Nephrol 38 (1992) 14-19
6. Lorini R., Scaramuzza A., Cortona L., Valenti G., and Annunzio G. Increased urinary N-acetyl-beta-d-glucosaminidase (NAG) excretion in young insulin-dependent diabetic patients. Diabetes Res Clin Prac 29 (1995) 99-105
7. Fuentes I.G., Blanco F.J.P., and Chica G.P. Clinical transcendence of urinary excretion of N-acetyl-beta-glucosaminidase in diabetic retinopathy. Arch Soc Esp Oftalmol 12 (2000) 1-6
8. Myśliwiec M., Balcerska A., Zorena K., Kamińska H., Nowacka M., Sibińska Ż., et al. Relationship between the level of TNFα, IL6 and risk of renal proximal tubules damage in children with newly diagnosed diabetes mellitus type 1. Pol J Environ Stud 14 suppl. II (2005) 292-295
9. Hussain M.J., Peakman M., Gallati H., Hawa M., Virerti G.C., Watkins P.J., et al. Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM. Diabetologia 39 (1996) 60-69
10. Myśliwska J., Skuratowicz-Kubica A., Zorena K., Horoszek-Maziarz B., and Myśliwski A. Hypothetical relationship between the presence of TNFα in the sera of insulin-dependent diabetes mellitus type I patients and control of the disease. Horm Metab Res 27 (1995) 255-257
11. Lin C.Y., Lin C.C., Chang G.J., and King C.C. Defect of cell-mediated immune response against hepatitis B virus: an indication for pathogenesis of hepatitis-B-virus-associated membranous nephropathy. Nephron 2 (1997) 176-185
12. Tipping P.G., Kitching A.R., Huang X.R., Mutch D.A., and Holdsworth S.R. Immune modulation with interleukin-4 and interleukin-10 prevents crescent formation and glomerular injury in experimental glomerulonephritis. Eur J Immunol 27 (1997) 530-537
13. Ridao N., Luno J., Garcia de Vinuesa S., Gomez F., Tejedor A., and Valderrabano F. Prevalence of hypertension in renal disease. Nephrol Dial Transplant 16 suppl 1 (2001) 70-73
14. Myśliwska J., Zorena K., Semetkowska-Jurkiewicz E., Rachoń D., Suchanek H., and Myśliwski A. High levels of circulating interleukin-10 in diabetic nephropathy patients. Eur Cytokine Netw 16 2 (2005 (Jun)) 117-122
15. American Diabetes Association: diagnosis and classification of diabetes. Diabetes Care 20 (1997) 1183-1197
16. ETDRS Report No 11. Classification of diabetic retinopathy from fluorescein angiograms ETDRS Research Group Ophthalmology 1991;98(suppl):807-22.
17. Agardh E., Hultberg B., and Agardh C.D. Effects of inhibition of glycation and oxidative stress on the development of cataract and retinal vessels abnormalities in diabetic rats. Curr Eye Res 21 (2000) 543-549
18. Beisswenger P.J., Makita Z., Curphey T.J., Moore L.L., Jean S., Brinck-Johnsen T., et al. Formation of immunochemical advanced glycosylation end-products precedes and correlates with early manifestations of renal and retinal disease in diabetes. Diabetes 44 (1995) 824-829
19. Lapolla A., Traldi P., and Fedele D. Importance of measuring products of non-enzymatic glycation of proteins. Clin Biochem 38 (2005) 103-115
20. Sugimoto H., Shikata K., Wada J., Horiuchi S., and Makino H. Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the overexpression of tumor necrosis factor-α and inducible nitric oxide synthase in diabetic glomeruli. Diabetologia 42 (1999) 878-886
21. Wolf G. New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology. Eur J Clin Invest 34 (2004) 785-796
22. Dolhofer R., Siess E.A., and Wieland O.H. Inactivation of bovine kidney B-N-acetyl-d-glucosaminidase by nonenzymatic glucosylation. Hoppe Seylers Z Physiol Chem 363 (1982) 1427-1436
23. Morohoshi M., Fujisawa K., Uchimura I., and Numano F. Glucose-dependent interleukin-6 and tumor necrosis factor production by peripheard blood monocytes in vitro. Diabetes 45 (1996) 954-959
24. Hussain M.J., Peakman M., Gallati H., Hawa M., Virerti G.C., and Watkins P.J. Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM. Diabetologia 39 (1996) 60-69
25. Limb G.A., Soomro H., Janikoun S., Hollifield R.D., and Shilling J. Evidence for control of tumor necrosis factor-alpha (TNF-alpha) activity by TNF receptors in patients with proliferative diabetic retinopathy. Clin Exp Immunol 115 (1999) 409-414
26. Doganay S., Evereklioglu C., Turkoz E.R.H., Sevinc A., Mehmet N., and Savli H. Comparison of serum NO, TNFα, IL-1β, Sil-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus. Eye 16 (2002) 163-170
27. Hasegawa G., Nakano K., Sawada M., Uno K., Shibayama Y., Ienaga K., et al. Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy. Kidney Int 40 (1991) 1007-1012
28. Nakamura T., Fukui M., Ebihara I., Osada S., Nagaoka I., Tomino Y., et al. mRNA expression on growth factors in glomeruli from diabetic rats. Diabetes 42 (1993) 450-456
29. Lorini R., De Amici M., d'Annunizo G., Vitali L., and Scaramuzza A. Low serum levels of tumor necrosis factor-alpha in insulin-dependent diabetic children. Horm Res 43 (1995) 206-209
30. Vitali L., De Amici M., d'Annunizo G., Martinetti M., Alibrandi A., and Lorini R. Low serum TNF-alpha levels in subjects at risk for type 1 diabetes. J Pediatr Endocrinol Metab 13 (2000) 475-481
31. Romano M., Pomilio M., Vigneri S., Falco A., Chiesa P.L., Chiarelli F., et al. Endothelial preturbation in children and adolescents with type 1 diabetes. Diabetes Care 24 (2001) 1674-1678
32. Jones A.P., Lock S., and Griffiths K.D. Urinary N-acetyl-beta-glucosaminidase activity in type 1 diabetes mellitus. Am Clin Biochem 32 (1995) 58-62
33. Hsiao P.H., Tsai W.S., Tsai W.Y., and Lee J.S. Urinary N-acetyl-beta-d-glucosaminidase activity in children with insulin-dependent diabetes mellitus. Am J Nephrol 16 (1996) 300-303
34. Kordonouri O., Hartmann R., Muller C., Danne T., and Weber B. Predictive value of tubular markers for the development of microalbuminuria in adolescents with diabetes. Horm Res 50 (1998) 23-27
35. Agard C.D., Agard E., and Isacksson A. Association between urinary N-acetyl-beta-glucosaminidase and its isoenzyme patterns and microangiopathy in type 1 diabetes mellitus. Clin Chem 37 (1991) 1.696-1.699
36. Yuuki T., Kanda T., Kimura Y., Kotajima N., Tamura J., and Kobayashi I. Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy. J Diabetes Complications 15 (2001) 257-259
37. Chatterjee P.K., Hawksworth G.M., and McLay J.S. Cytokine-stimulated nitric oxide production in the human renal proximal tubule and its modulation by natriuretic peptides: a novel immunomodulatory mechanism?. Exp Nephrol 7 (1999) 438-448
38. Markewitz B.A., Michael J.R., and Kohan D.E. Cytokine-induced expression of a nitric oxide synthase in rat renal tubule cells. J Clin Incest 91 (1993) 2138-2143
39. McBride W.T., and McBride S.J. The balance of pro- and anti-inflammatory cytokines in cardiac surgery. Curr Opin Anaesth 11 (1998) 15-22
40. Ng W.Y., Thai A.C., Lui K.F., and Yeo P.P. Systemic levels of cytokines and GAD-specific autoantibodies isotypes in Chinese IDDM patients. Diabetes Res Clin Pract 43 (1999) 127-141
41. Takeuchi M., Keino H., Kezuka T., Usui M., and Taguchi O. Immune responses to retinal self antigens in CD25(+)CD4(+) regulatory T-cell-depleted mice. Invest Ophthalmol Vis Sci 45 (2004) 1879-1886
42. Kumar A., Zanotii S., Bunnell G., Habet K., Anel R., Neumann A., et al. Interleukin-10 blunts the human inflammatory response to lipopolysaccharide without affecting the cardiovascular response. Crit Care Med 33 (2005) 331-340
43. Asadullah K., Sabat R., Friedrich M., Volk H.D., and Sterry W. Interleukin-10: an important immunoregulatory cytokine with major impact on psoriasis. Curr Drug Targets Inflamm Allergy 3 (2004) 185-192